Why IMU is a multi multi bagger, page-195

Volatility works both ways, and show us a time when has Imu not bounced back.?

October / November easily could see two new IND approvals, first dosing in PD1 Vax, a second IDMC HerVax safety update, interim data for HerVax, potentially an accelerated approval status granted by FDA , and LC exercise another 50,000,000 of her outstanding options. All those things together in the next month or two will push this towards 20c minimum . Add in some genuine fresh brokerage research with meaningful upside price target. Oh, and what about a Big Pharma HerVax licensing deal with a $200million upfront payment based on successful interim data readout? 30c+ . With an upfront payment distribution with more to follow.

The risk is to the upside because none of these things are remotely “priced in “ below 10c